# Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects

> **NCT01020877** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 38 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Metronidazole
- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT01020877
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2001-11
- **Final completion:** 2002-01
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2010-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01020877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01020877, "Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01020877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*